1. OP03 Telaprevir-based therapy in G1 HCV-infected patients with prior null response, partial response or relapse to peginterferon/ribavirin: REALIZE trial final results. (6th September 2011) Authors: Foster, G; Zeuzem, S; Andreone, P; Pol, S; Lawitz, E; Diago, M; Roberts, S; Focaccia, R; Younossi, Z; A H, ; Heeswijk, R V; de Meyer, S; Luo, D; Picchio, G; Beumont, M Journal: Gut Issue: Volume 60:(2011)Supplement 2 Page Start: A50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP12 Similar Svr Rates In Il28b Cc, Ct Or Tt prior relapser, partial- or null-responder patients treated with telaprevir/peginterferon/ribavirin: retrospective analysis of the Realize Study. (6th September 2011) Authors: Foster, G R; Pol, S; Aerssens, J; Zeuzem, S; Andreone, P; Lawitz, E J; Roberts, S; Younossi, Z; Focaccia, R; Horban, A; Pockros, P J; Van Heeswijk, R; de Meyer, S; Luo, D; Beumont, M; Picchio, G Journal: Gut Issue: Volume 60:(2011)Supplement 2 Page Start: A55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗